The effect of combined treatment with sodium phenylbutyrate and cisplatin, erlotinib, or gefitinib on resistant NSCLC cells

Maha S Al-Keilani,1 Karem H Alzoubi,1 Saied A Jaradat2,3 1Department of Clinical Pharmacy, College of Pharmacy, Jordan University of Science and Technology, Irbid 22110, Jordan; 2Department of Biotechnology and Genetic Engineering, Jordan University of Science and Technology, Irbid 22110, Jordan; 3P...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Al-Keilani MS (Autor), Alzoubi KH (Autor), Jaradat SA (Autor)
Format: Llibre
Publicat: Dove Medical Press, 2018-10-01T00:00:00Z.
Matèries:
Accés en línia:Connect to this object online.
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Internet

Connect to this object online.

3rd Floor Main Library

Detall dels fons de 3rd Floor Main Library
Signatura: A1234.567
Còpia 1 Disponible